A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Summary: New research reveals dopamine has a previously unknown role: reshaping our memories of rewarding experiences. In a ...

Patients' own stem cells to replace damaged dopamine cells in Parkinson’s disease, offering new hope. Parkinson's disease - ...

New research out of Michigan State University expands on current understanding of the brain chemical dopamine, finding that ...

Cell replacement for Parkinson’s disease replaces the dopamine neurons lost to degeneration and can restore dopaminergic function in the brain, providing a completely new treatment modality ...

A pioneering Phase 1 clinical trial, reported in a March 9, 2025, ScienceDaily article, is advancing stem cell therapies for Parkinson's disease. After over 30 years of research, the trial reprograms ...

Parkinson's Disease has an early onset form, which affects patients before they reach age 50, and is due to genetic mutations. | Genetics And Genomics ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem ...